EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (5 days ago)
New #douglasconnect Risk Assessment Application makes #chemicalsafety assessment reliable, meaningful. Succeeds by… https://t.co/1OO787ejMx
Douglas Connect (5 days ago)
InnovationWell - A New Era in Using Natural Products for Drug Development and Health - Join us in Basel, November 2… https://t.co/MbctFchSb4
Douglas Connect (2 weeks ago)
New Risk Assessment app brings data together - read about our new app here: https://t.co/aIL7uFPllV …… https://t.co/cJrkj8lC70
Douglas Connect (2 weeks ago)
InnovationWell comes to Basel, OpenRiskNet launches its new website, read the November 2018 Douglas Connect Newslet… https://t.co/VJ4Eg3pH9a
Douglas Connect (3 weeks ago)
Could modern information technology provide the missing link to make full use of the hundreds of thousands of compo… https://t.co/2jop0bnxmA

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com